Report Code : CVMI29112024 | Published Date : Nov. 29, 2024
Reasons To Buy
Scope
Wedgewood Pharmacy
Diamondback Drugs
Medisca Inc.
Patterson Veterinary Pharmacy
Central Compounding Center South
Plumb’s Veterinary Drugs
Chiron Compounding Pharmacy
Bluegrass Veterinary Compounding Pharmacy
MedVet
Clingman Pharmacy
Patterson Companies Inc.
BCP Veterinary Pharmacy
Millers Pharmacy
CareFirst Specialty Pharmacy
Henry Schein Animal Health
| 1. Global Veterinary Compounding Pharmacies Market Research Report |
| 1.1 Study Objectives |
| 1.2 Veterinary Compounding Pharmacies Market - Overview |
| 1.3 Reasons to Read This Report |
| 1.4 Methodology and Forecast Analysis |
| 2. Global Veterinary Compounding Pharmacies Market Research Report - Preface |
| 2.1 Global Veterinary Compounding Pharmacies Market Research Report – Detailed Scope and Definitions |
| 2.1.1 By Product Type |
| 2.1.2 By Animal Type |
| 2.1.3 By Compounding Type |
| 2.1.4 By Formulation |
| 2.1.5 By Route of Administration |
| 2.1.6 By End-Use |
| 2.1.7 By Distribution Channel |
| 2.1.8 By Region |
| 3. Global Veterinary Compounding Pharmacies Market Dynamics |
| 3.1. Drivers - Macro-Economic Based, Supply Side, and Demand Side Drivers |
| 3.2. Restraints – By Product Type, By Animal Type, By Compounding Type, By Formulation, By Route of Administration, By End-Use, By Distribution Channel, By Country |
| 3.3. Opportunities – By Product Type, By Animal Type, By Compounding Type, By Formulation, By Route of Administration, By End-Use, By Distribution Channel, By Country |
| 3.4. Trends – By Product Type, By Animal Type, By Compounding Type, By Formulation, By Route of Administration, By End-Use, By Distribution Channel, By Country |
| 3.5. PEST Analysis |
| 3.6. Porters Five Rule Analysis |
| 3.7. Company’s Share Analysis (CSA) by Region or By Country |
| 3.8. Global Veterinary Compounding Pharmacies Market Research Report – DROTs Impact Analysis |
| 4. Global Veterinary Compounding Pharmacies Market Research Report , Historic Data 2019 - 2023 and Forecast Analysis Data 2024 - 2031 |
| 4.1.Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions) |
| 4.2.Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%). |
| 4.3.Incremental Market Value/Volume Opportunity between 2019 - 2023 and 2024 - 2031 |
| 4.4.Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 |
| 5. Global Veterinary Compounding Pharmacies Market, By Product Type, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn) |
| 5.1 Oral Medications (Capsules, Chewable Tablets, Powders Liquids) |
| 5.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions) |
| 5.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%) |
| 5.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031 |
| 5.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 |
| 5.2 Topical Medications (Creams, Ointments, Gels Lotions) |
| 5.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions) |
| 5.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%) |
| 5.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031 |
| 5.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 |
| 5.3 Injectable Medications (Sterile Injections, Vaccines) |
| 5.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions) |
| 5.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%) |
| 5.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031 |
| 5.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 |
| 5.4 Others (Suppositories, Transdermal Patches) |
| 5.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions) |
| 5.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%) |
| 5.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031 |
| 5.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 |
| 6. Global Veterinary Compounding Pharmacies Market, By Animal Type, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn) |
| 6.1 Companion Animals (Dogs, Cats, Other Pets, (Birds, Rabbits, etc.)) |
| 6.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions) |
| 6.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%) |
| 6.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031 |
| 6.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 |
| 6.2 Livestock Animals (Cattle, Poultry, Swine, Sheep and Goats) |
| 6.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions) |
| 6.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%) |
| 6.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031 |
| 6.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 |
| 6.3 Exotic Animals (Reptiles, Wildlife Animals, Zoo Animals) |
| 6.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions) |
| 6.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%) |
| 6.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031 |
| 6.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 |
| 7. Global Veterinary Compounding Pharmacies Market, By Compounding Type, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn) |
| 7.1 Flavoring |
| 7.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions) |
| 7.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%) |
| 7.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031 |
| 7.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 |
| 7.2 Dosage Alterations (Strength/Size) |
| 7.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions) |
| 7.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%) |
| 7.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031 |
| 7.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 |
| 7.3 Combination Compounding |
| 7.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions) |
| 7.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%) |
| 7.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031 |
| 7.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 |
| 7.4 Allergy-Friendly Compounding |
| 7.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions) |
| 7.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%) |
| 7.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031 |
| 7.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 |
| 7.5 Discontinued Drug Compounding |
| 7.5.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions) |
| 7.5.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%) |
| 7.5.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031 |
| 7.5.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 |
| 8. Global Veterinary Compounding Pharmacies Market, By Formulation, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn) |
| 8.1 Solid Dosage Forms |
| 8.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions) |
| 8.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%) |
| 8.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031 |
| 8.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 |
| 8.2 Liquid Dosage Forms |
| 8.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions) |
| 8.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%) |
| 8.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031 |
| 8.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 |
| 8.3 Semi-Solid Dosage Forms |
| 8.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions) |
| 8.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%) |
| 8.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031 |
| 8.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 |
| 8.4 Aerosolized Forms |
| 8.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions) |
| 8.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%) |
| 8.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031 |
| 8.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 |
| 9. Global Veterinary Compounding Pharmacies Market, By Route of Administration, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn) |
| 9.1 Oral |
| 9.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions) |
| 9.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%) |
| 9.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031 |
| 9.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 |
| 9.2 Topical |
| 9.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions) |
| 9.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%) |
| 9.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031 |
| 9.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 |
| 9.3 Parenteral (Injectable) |
| 9.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions) |
| 9.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%) |
| 9.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031 |
| 9.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 |
| 9.4 Ophthalmic |
| 9.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions) |
| 9.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%) |
| 9.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031 |
| 9.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 |
| 9.5 Others |
| 9.5.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions) |
| 9.5.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%) |
| 9.5.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031 |
| 9.5.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 |
| 10. Global Veterinary Compounding Pharmacies Market, By End-Use, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn) |
| 10.1 Veterinary Hospitals |
| 10.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions) |
| 10.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%) |
| 10.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031 |
| 10.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 |
| 10.2 Veterinary Clinics |
| 10.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions) |
| 10.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%) |
| 10.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031 |
| 10.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 |
| 10.3 Homecare Settings |
| 10.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions) |
| 10.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%) |
| 10.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031 |
| 10.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 |
| 10.4 Research Institutes |
| 10.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions) |
| 10.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%) |
| 10.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031 |
| 10.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 |
| 11. Global Veterinary Compounding Pharmacies Market, By Distribution Channel, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn) |
| 11.1 Retail Pharmacies |
| 11.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions) |
| 11.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%) |
| 11.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031 |
| 11.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 |
| 11.2 Online Pharmacies |
| 11.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions) |
| 11.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%) |
| 11.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031 |
| 11.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 |
| 11.3 Veterinary Pharmacies |
| 11.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions) |
| 11.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%) |
| 11.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031 |
| 11.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 |
| 11.4 Hospital Pharmacies |
| 11.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions) |
| 11.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%) |
| 11.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031 |
| 11.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 |
| 12. Global Veterinary Compounding Pharmacies Market Forecast, By Region, 2019 - 2023 and 2024 - 2031 (Market Value, In USD Mn) |
| 12.1 North America |
| 12.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions) |
| 12.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%) |
| 12.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031 |
| 12.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 |
| 12.2 Latin America |
| 12.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions) |
| 12.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%) |
| 12.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031 |
| 12.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 |
| 12.3 Europe |
| 12.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions) |
| 12.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%) |
| 12.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031 |
| 12.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 |
| 12.4 Asia-Pacific |
| 12.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions) |
| 12.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%) |
| 12.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031 |
| 12.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 |
| 12.5 Middle East and Africa |
| 12.5.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions) |
| 12.5.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%) |
| 12.5.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031 |
| 12.5.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031 |
| 12.6 Global Veterinary Compounding Pharmacies Market - Opportunity Analysis Index, By Product Type, By Animal Type, By Compounding Type, By Formulation, By Route of Administration, By End-Use, By Distribution Channel, and Region, 2024 - 2031 |
| 13. North America Veterinary Compounding Pharmacies Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn) |
| 13.1 By Product Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
| 13.1.1 Oral Medications (Capsules, Chewable Tablets, Powders Liquids) |
| 13.1.2 Topical Medications (Creams, Ointments, Gels Lotions) |
| 13.1.3 Injectable Medications (Sterile Injections, Vaccines) |
| 13.1.4 Others (Suppositories, Transdermal Patches) |
| 13.2 By Animal Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
| 13.2.1 Companion Animals (Dogs, Cats, Other Pets, (Birds, Rabbits, etc.)) |
| 13.2.2 Livestock Animals (Cattle, Poultry, Swine, Sheep and Goats) |
| 13.2.3 Exotic Animals (Reptiles, Wildlife Animals, Zoo Animals) |
| 13.3 By Compounding Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
| 13.3.1 Flavoring |
| 13.3.2 Dosage Alterations (Strength/Size) |
| 13.3.3 Combination Compounding |
| 13.3.4 Allergy-Friendly Compounding |
| 13.3.5 Discontinued Drug Compounding |
| 13.4 By Formulation Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
| 13.4.1 Solid Dosage Forms |
| 13.4.2 Liquid Dosage Forms |
| 13.4.3 Semi-Solid Dosage Forms |
| 13.4.4 Aerosolized Forms |
| 13.5 By Route of Administration Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
| 13.5.1 Oral |
| 13.5.2 Topical |
| 13.5.3 Parenteral (Injectable) |
| 13.5.4 Ophthalmic |
| 13.5.5 Others |
| 13.6 By End-Use Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
| 13.6.1 Veterinary Hospitals |
| 13.6.2 Veterinary Clinics |
| 13.6.3 Homecare Settings |
| 13.6.4 Research Institutes |
| 13.7 By Distribution Channel Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
| 13.7.1 Retail Pharmacies |
| 13.7.2 Online Pharmacies |
| 13.7.3 Veterinary Pharmacies |
| 13.7.4 Hospital Pharmacies |
| 13.8 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
| 13.8.1 USA |
| 13.8.2 Canada |
| 13.9 North America Veterinary Compounding Pharmacies Market – Opportunity Analysis Index, By Product Type, By Animal Type, By Compounding Type, By Formulation, By Route of Administration, By End-Use, By Distribution Channel, and Country, 2024 - 2031 |
| 13.10 Regional Trends Analysis |
| 13.11 North America Veterinary Compounding Pharmacies Market Research Report - Company Profiles |
| 13.11.1 Company 1 (USA) |
| 13.11.2 Company 2 (Canada) |
| 13.11.3 Company 3 (Canada) |
| 14. Latin America Veterinary Compounding Pharmacies Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn) |
| 14.1 By Product Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
| 14.1.1 Oral Medications (Capsules, Chewable Tablets, Powders Liquids) |
| 14.1.2 Topical Medications (Creams, Ointments, Gels Lotions) |
| 14.1.3 Injectable Medications (Sterile Injections, Vaccines) |
| 14.1.4 Others (Suppositories, Transdermal Patches) |
| 14.2 By Animal Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
| 14.2.1 Companion Animals (Dogs, Cats, Other Pets, (Birds, Rabbits, etc.)) |
| 14.2.2 Livestock Animals (Cattle, Poultry, Swine, Sheep and Goats) |
| 14.2.3 Exotic Animals (Reptiles, Wildlife Animals, Zoo Animals) |
| 14.3 By Compounding Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
| 14.3.1 Flavoring |
| 14.3.2 Dosage Alterations (Strength/Size) |
| 14.3.3 Combination Compounding |
| 14.3.4 Allergy-Friendly Compounding |
| 14.3.5 Discontinued Drug Compounding |
| 14.4 By Formulation Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
| 14.4.1 Solid Dosage Forms |
| 14.4.2 Liquid Dosage Forms |
| 14.4.3 Semi-Solid Dosage Forms |
| 14.4.4 Aerosolized Forms |
| 14.5 By Route of Administration Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
| 14.5.1 Oral |
| 14.5.2 Topical |
| 14.5.3 Parenteral (Injectable) |
| 14.5.4 Ophthalmic |
| 14.5.5 Others |
| 14.6 By End-Use Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
| 14.6.1 Veterinary Hospitals |
| 14.6.2 Veterinary Clinics |
| 14.6.3 Homecare Settings |
| 14.6.4 Research Institutes |
| 14.7 By Distribution Channel Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
| 14.7.1 Retail Pharmacies |
| 14.7.2 Online Pharmacies |
| 14.7.3 Veterinary Pharmacies |
| 14.7.4 Hospital Pharmacies |
| 14.8 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
| 14.8.1 Brazil |
| 14.8.2 Mexico |
| 14.8.3 Argentina |
| 14.8.4 Colombia |
| 14.8.5 Rest of Latin America |
| 14.9 Latin America Veterinary Compounding Pharmacies Market – Opportunity Analysis Index, By Product Type, By Animal Type, By Compounding Type, By Formulation, By Route of Administration, By End-Use, By Distribution Channel, and Country, 2024 - 2031 |
| 14.10 Regional Trends Analysis |
| 14.11 Latin America Veterinary Compounding Pharmacies Market Research Report - Company Profiles |
| 14.11.1 Company 1 (Brazil) |
| 14.11.2 Company 2 (Mexico) |
| 14.11.3 Company 3 (Mexico) |
| 15. Europe Veterinary Compounding Pharmacies Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn) |
| 15.1 By Product Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
| 15.1.1 Oral Medications (Capsules, Chewable Tablets, Powders Liquids) |
| 15.1.2 Topical Medications (Creams, Ointments, Gels Lotions) |
| 15.1.3 Injectable Medications (Sterile Injections, Vaccines) |
| 15.1.4 Others (Suppositories, Transdermal Patches) |
| 15.2 By Animal Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
| 15.2.1 Companion Animals (Dogs, Cats, Other Pets, (Birds, Rabbits, etc.)) |
| 15.2.2 Livestock Animals (Cattle, Poultry, Swine, Sheep and Goats) |
| 15.2.3 Exotic Animals (Reptiles, Wildlife Animals, Zoo Animals) |
| 15.3 By Compounding Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
| 15.3.1 Flavoring |
| 15.3.2 Dosage Alterations (Strength/Size) |
| 15.3.3 Combination Compounding |
| 15.3.4 Allergy-Friendly Compounding |
| 15.3.5 Discontinued Drug Compounding |
| 15.4 By Formulation Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
| 15.4.1 Solid Dosage Forms |
| 15.4.2 Liquid Dosage Forms |
| 15.4.3 Semi-Solid Dosage Forms |
| 15.4.4 Aerosolized Forms |
| 15.5 By Route of Administration Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
| 15.5.1 Oral |
| 15.5.2 Topical |
| 15.5.3 Parenteral (Injectable) |
| 15.5.4 Ophthalmic |
| 15.5.5 Others |
| 15.6 By End-Use Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
| 15.6.1 Veterinary Hospitals |
| 15.6.2 Veterinary Clinics |
| 15.6.3 Homecare Settings |
| 15.6.4 Research Institutes |
| 15.7 By Distribution Channel Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
| 15.7.1 Retail Pharmacies |
| 15.7.2 Online Pharmacies |
| 15.7.3 Veterinary Pharmacies |
| 15.7.4 Hospital Pharmacies |
| 15.8 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
| 15.8.1 United Kingdom |
| 15.8.2 Germany |
| 15.8.3 France |
| 15.8.4 Spain |
| 15.8.5 Italy |
| 15.8.6 Russia |
| 15.8.7 Rest of Europe |
| 15.9 Europe Veterinary Compounding Pharmacies Market – Opportunity Analysis Index, By Product Type, By Animal Type, By Compounding Type, By Formulation, By Route of Administration, By End-Use, By Distribution Channel, and Country, 2024 - 2031 |
| 15.10 Regional Trends Analysis |
| 15.11 Europe Veterinary Compounding Pharmacies Market Research Report - Company Profiles |
| 15.11.1 Company 1 (United Kingdom) |
| 15.11.2 Company 2 (Germany) |
| 15.11.3 Company 3 (Germany) |
| 16. Asia-Pacific Veterinary Compounding Pharmacies Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn) |
| 16.1 By Product Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
| 16.1.1 Oral Medications (Capsules, Chewable Tablets, Powders Liquids) |
| 16.1.2 Topical Medications (Creams, Ointments, Gels Lotions) |
| 16.1.3 Injectable Medications (Sterile Injections, Vaccines) |
| 16.1.4 Others (Suppositories, Transdermal Patches) |
| 16.2 By Animal Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
| 16.2.1 Companion Animals (Dogs, Cats, Other Pets, (Birds, Rabbits, etc.)) |
| 16.2.2 Livestock Animals (Cattle, Poultry, Swine, Sheep and Goats) |
| 16.2.3 Exotic Animals (Reptiles, Wildlife Animals, Zoo Animals) |
| 16.3 By Compounding Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
| 16.3.1 Flavoring |
| 16.3.2 Dosage Alterations (Strength/Size) |
| 16.3.3 Combination Compounding |
| 16.3.4 Allergy-Friendly Compounding |
| 16.3.5 Discontinued Drug Compounding |
| 16.4 By Formulation Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
| 16.4.1 Solid Dosage Forms |
| 16.4.2 Liquid Dosage Forms |
| 16.4.3 Semi-Solid Dosage Forms |
| 16.4.4 Aerosolized Forms |
| 16.5 By Route of Administration Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
| 16.5.1 Oral |
| 16.5.2 Topical |
| 16.5.3 Parenteral (Injectable) |
| 16.5.4 Ophthalmic |
| 16.5.5 Others |
| 16.6 By End-Use Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
| 16.6.1 Veterinary Hospitals |
| 16.6.2 Veterinary Clinics |
| 16.6.3 Homecare Settings |
| 16.6.4 Research Institutes |
| 16.7 By Distribution Channel Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
| 16.7.1 Retail Pharmacies |
| 16.7.2 Online Pharmacies |
| 16.7.3 Veterinary Pharmacies |
| 16.7.4 Hospital Pharmacies |
| 16.8 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
| 16.8.1 China |
| 16.8.2 Japan |
| 16.8.3 India |
| 16.8.4 Australia & New Zealand |
| 16.8.5 South Korea |
| 16.8.6 ASEAN |
| 16.8.7 Rest of Asia-Pacific |
| 16.9 Asia-Pacific Veterinary Compounding Pharmacies Market – Opportunity Analysis Index, By Product Type, By Animal Type, By Compounding Type, By Formulation, By Route of Administration, By End-Use, By Distribution Channel, and Country, 2024 - 2031 |
| 16.10 Regional Trends Analysis |
| 16.11 Asia-Pacific Veterinary Compounding Pharmacies Market Research Report - Company Profiles |
| 16.11.1 Company 1 (China) |
| 16.11.2 Company 2 (Japan) |
| 16.11.3 Company 3 (Japan) |
| 17. Middle East and Africa Veterinary Compounding Pharmacies Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn) |
| 17.1 By Product Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
| 17.1.1 Oral Medications (Capsules, Chewable Tablets, Powders Liquids) |
| 17.1.2 Topical Medications (Creams, Ointments, Gels Lotions) |
| 17.1.3 Injectable Medications (Sterile Injections, Vaccines) |
| 17.1.4 Others (Suppositories, Transdermal Patches) |
| 17.2 By Animal Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
| 17.2.1 Companion Animals (Dogs, Cats, Other Pets, (Birds, Rabbits, etc.)) |
| 17.2.2 Livestock Animals (Cattle, Poultry, Swine, Sheep and Goats) |
| 17.2.3 Exotic Animals (Reptiles, Wildlife Animals, Zoo Animals) |
| 17.3 By Compounding Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
| 17.3.1 Flavoring |
| 17.3.2 Dosage Alterations (Strength/Size) |
| 17.3.3 Combination Compounding |
| 17.3.4 Allergy-Friendly Compounding |
| 17.3.5 Discontinued Drug Compounding |
| 17.4 By Formulation Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
| 17.4.1 Solid Dosage Forms |
| 17.4.2 Liquid Dosage Forms |
| 17.4.3 Semi-Solid Dosage Forms |
| 17.4.4 Aerosolized Forms |
| 17.5 By Route of Administration Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
| 17.5.1 Oral |
| 17.5.2 Topical |
| 17.5.3 Parenteral (Injectable) |
| 17.5.4 Ophthalmic |
| 17.5.5 Others |
| 17.6 By End-Use Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
| 17.6.1 Veterinary Hospitals |
| 17.6.2 Veterinary Clinics |
| 17.6.3 Homecare Settings |
| 17.6.4 Research Institutes |
| 17.7 By Distribution Channel Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
| 17.7.1 Retail Pharmacies |
| 17.7.2 Online Pharmacies |
| 17.7.3 Veterinary Pharmacies |
| 17.7.4 Hospital Pharmacies |
| 17.8 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%) |
| 17.8.1 UAE |
| 17.8.2 Saudi Arabia |
| 17.8.3 South Africa |
| 17.8.4 Egypt |
| 17.8.5 Israel |
| 17.8.6 Morocco |
| 17.8.7 Rest of Middle East and Africa |
| 17.9 Middle East and Africa Veterinary Compounding Pharmacies Market – Opportunity Analysis Index, By Product Type, By Animal Type, By Compounding Type, By Formulation, By Route of Administration, By End-Use, By Distribution Channel, and Country, 2024 - 2031 |
| 17.10 Regional Trends Analysis |
| 17.11 Middle East and Africa Veterinary Compounding Pharmacies Market Research Report - Company Profiles |
| 17.11.1 Company 1 (UAE) |
| 17.11.2 Company 2 (Saudi Arabia) |
| 17.11.3 Company 3 (Saudi Arabia) |
| 18. Competition Landscape |
| 18.1 Strategic Dashboard of Top Market Players |
| 18.2 Company Profiles (Introduction, Financial Assessments, Portfolio of Offerings, Milestones and Achievements, Strategic Initiative, and SWOT Analysis) |
| 18.2.1 Wedgewood Pharmacy |
| 18.2.2 Diamondback Drugs |
| 18.2.3 Medisca Inc. |
| 18.2.4 Patterson Veterinary Pharmacy |
| 18.2.5 Central Compounding Center South |
| 18.2.6 Plumb’s Veterinary Drugs |
| 18.2.7 Chiron Compounding Pharmacy |
| 18.2.8 Bluegrass Veterinary Compounding Pharmacy |
| 18.2.9 MedVet |
| 18.2.10 Clingman Pharmacy |
| 18.2.11 Patterson Companies Inc. |
| 18.2.12 BCP Veterinary Pharmacy |
| 18.2.13 Millers Pharmacy |
| 18.2.14 CareFirst Specialty Pharmacy |
| 18.2.15 Henry Schein Animal Health. |
| 19. Data Collection Method and Research Approach |
| 20. Principal Presumptions and Acronyms |
